Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...
As we reflect on 2024, I am proud to share the remarkable progress Atossa Therapeutics has made in advancing our mission to address significant unmet needs in breast cancer prevention and treatment.
In this clinical trial, 4742 postmenopausal women in 37 countries who had received initial treatment for unilateral estrogen-receptor-positive breast cancer and had been taking adjuvant tamoxifen ...
Nat Clin Pract Oncol. 2008;5(9):531-542. Thus, in HR + /HER2 + breast tumors a vicious cycle is established between ER genomic and non-genomic mechanisms of action and the growth factor receptor ...
Health Digest on MSN4d
Popular Medications That Could Reduce Your Risk Of Dying From CancerWe have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - ...
Scientists have developed a single-dose treatment for breast cancer that eliminates small tumors and significantly shrinks ...
Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment ...
2021.03.003 Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback